These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 15999056)

  • 1. The maximum standardized uptake values on positron emission tomography of a non-small cell lung cancer predict stage, recurrence, and survival.
    Cerfolio RJ; Bryant AS; Ohja B; Bartolucci AA
    J Thorac Cardiovasc Surg; 2005 Jul; 130(1):151-9. PubMed ID: 15999056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. More Frequent Surveillance Following Lung Cancer Resection Is Not Associated With Improved Survival: A Nationally Representative Cohort Study.
    McMurry TL; Stukenborg GJ; Kessler LG; Colditz GA; Wong ML; Francescatti AB; Jones DR; Schumacher JR; Greenberg CC; Chang GJ; Winchester DP; McKellar DP; Kozower BD
    Ann Surg; 2018 Oct; 268(4):632-639. PubMed ID: 30004919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging in Lung Cancer Staging.
    Strange CD; Strange TA; Erasmus LT; Patel S; Ahuja J; Shroff GS; Agrawal R; Truong MT
    Clin Chest Med; 2024 Jun; 45(2):295-305. PubMed ID: 38816089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized phase III trial of postoperative surveillance for pathological stage II and IIIA non-small cell lung cancer (JCOG2012, PHOENIX).
    Tane K; Shiono S; Wakabayashi M; Kataoka T; Mitome N; Fukuda H; Aokage K; Watanabe SI;
    Jpn J Clin Oncol; 2024 Aug; 54(8):926-929. PubMed ID: 38693750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Value of Fluoro-D-glucose Uptake of Primary Tumor and Metastatic Lesions in Advanced Nonsmall Cell Lung Cancer.
    Nguyen XC; Nguyen VK; Tran MT; Maurea S; Salvatore M
    World J Nucl Med; 2014 May; 13(2):112-9. PubMed ID: 25191126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesorectal thromboembolism with increased
    Sato Y; Tsujinaka S; Miura T; Kitamura Y; Sawada K; Mitamura A; Yamamoto K; Nakano T; Katayose Y; Shibata C
    J Surg Case Rep; 2024 Jul; 2024(7):rjae457. PubMed ID: 39005639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential Survival Benefit of Upfront Surgery for Lung Tumors Unconfirmed but Highly Suspicious for Stage I Lung Cancer.
    Kara M; Erdogdu E; Duman S; Fatalizade G; Ozkan B; Toker A
    J Chest Surg; 2024 Sep; 57(5):440-446. PubMed ID: 38835210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of Resected Lung Cancer Diagnosed Through Screening and Incidental Pulmonary Nodule Programs in a Mississippi Delta Cohort.
    Akinbobola O; Liao W; Ray MA; Fehnel C; Goss J; Qureshi T; Saulsberry A; Dortch K; Smeltzer MP; Osarogiagbon RU
    JTO Clin Res Rep; 2024 Aug; 5(8):100684. PubMed ID: 39157675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correction: Maximum standardized uptake value in 
    Kuroshima T; Kitagawa Y; Sato J; Watanabe S; Asaka T; Abe T; Harada H; Hirata K; Kuge Y
    Odontology; 2024 May; ():. PubMed ID: 38767723
    [No Abstract]   [Full Text] [Related]  

  • 10. Maximum standard uptake value of mediastinal lymph nodes on integrated FDG-PET-CT predicts pathology in patients with non-small cell lung cancer.
    Bryant AS; Cerfolio RJ; Klemm KM; Ojha B
    Ann Thorac Surg; 2006 Aug; 82(2):417-22; discussion 422-3. PubMed ID: 16863739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beneficial implications of adjuvant chemotherapy for stage IB lung adenocarcinoma exhibiting elevated SUVmax in FDG-PET/CT: a retrospective study from a single center.
    Huang M; Liu B; Li X; Li N; Yang X; Wang Y; Zhang S; Lu F; Li S; Yan S; Wu N
    Front Oncol; 2024; 14():1367200. PubMed ID: 38529383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between 18-FDG standardized uptake value and tumor grade in patients with resectable non-small cell lung cancer.
    Kużdżał B; Moszczyński K; Żanowska K; Hauer J; Popovchenko S; Bryndza M; Warmus J; Trybalski Ł; Rudnicka L; Kocoń P
    Transl Cancer Res; 2023 Dec; 12(12):3530-3537. PubMed ID: 38192987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor to liver maximum standardized uptake value ratio of FDG-PET/CT parameters predicts tumor treatment response and survival of stage III non-small cell lung cancer.
    Zhang P; Chen W; Zhao K; Qiu X; Li T; Zhu X; Sun P; Wang C; Song Y
    BMC Med Imaging; 2023 Aug; 23(1):107. PubMed ID: 37582701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Additional Value of PET and CT Image-Based Features in the Detection of Occult Lymph Node Metastases in Lung Cancer: A Systematic Review of the Literature.
    Guglielmo P; Marturano F; Bettinelli A; Sepulcri M; Pasello G; Gregianin M; Paiusco M; Evangelista L
    Diagnostics (Basel); 2023 Jun; 13(13):. PubMed ID: 37443547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between Imaging Markers Derived from PET/MRI and Invasive Acquired Biomarkers in Newly Diagnosed Breast Cancer.
    Jannusch K; Bittner AK; Bruckmann NM; Morawitz J; Stieglitz C; Dietzel F; Quick HH; Baba HA; Herrmann K; Umutlu L; Antoch G; Kirchner J; Kasimir-Bauer S; Hoffmann O
    Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GLUT1 and PKM2 may be useful prognostic predictors in patients with non‑small cell lung cancer following curative R0 resection.
    Ito R; Yashiro M; Tsukioka T; Izumi N; Komatsu H; Inoue H; Yamamoto Y; Nishiyama N
    Oncol Lett; 2023 Mar; 25(3):129. PubMed ID: 36844619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do fine needle aspirate cytomorphological features correlate with positron emission tomography findings of metastatic non-small cell lung carcinoma in lymph nodes?
    Keyhanian K; Sekhon HS
    Cancer Med; 2023 Apr; 12(7):8218-8227. PubMed ID: 36691354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Value of Positron Emission Tomography in Advanced Cholangiocarcinoma: A Single-Institution Study and Literature Review.
    Pevner JL; Tanvetyanon T
    Cureus; 2022 Nov; 14(11):e31026. PubMed ID: 36475189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of
    Ling T; Zhang L; Peng R; Yue C; Huang L
    Front Immunol; 2022; 13():1014063. PubMed ID: 36466905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of
    Zoair M; Taber S; Bittner R; Foerster G; Griff S; Bauer TT; Pfannschmidt J
    Innov Surg Sci; 2022 Jun; 7(2):35-43. PubMed ID: 36317010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.